Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

Viatris

Status

Completed

Conditions

Chronic Heart Failure

Treatments

Drug: Eplerenone

Study type

Observational

Funder types

Industry

Identifiers

NCT03342690

A6141122

Details and patient eligibility

About

Secondary Data Collection Study; Safety And Effectiveness Of Selara Under Japanese Medical Practice

Full description

This study will be conducted under the central registration system until the number of subjects who meet the conditions for registration reaches the target number of subjects. The patients will be observed up until Week 52.

Enrollment

1,165 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients in whom treatment with this drug is for CHF. The indications at approval for this drug are as follows. When using this drug, refer to the latest package insert of this drug.

Exclusion criteria

Patients who were previously registered for this study. Patients who received eplerenone within the past three months regardless of the reason for use.